Hanna Iderberg

A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys

Daniella Rylander Ottosson, Hanna Iderberg, Qin Li et al. · Neurobiology of Disease · 2010 · 149 citations · Full text

Mglur5 Antagonist, Medicine, Functional Selectivity +8

NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat

Hanna Iderberg, Andrew C. McCreary, Mark A. Varney et al. · Experimental Neurology · 2015 · 76 citations

Novel 5-Ht 1A, Neurochemical Profile, Behavioral Neuroscience +12

Activity of serotonin 5-HT1A receptor ‘biased agonists’ in rat models of Parkinson's disease and l-DOPA-induced dyskinesia

Hanna Iderberg, Andrew C. McCreary, Mark A. Varney et al. · Neuropharmacology · 2015 · 67 citations

Neurophysiology, Medicine, Neurotransmitter +9

Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist

Hanna Iderberg, Natallia Maslava, Analisa D. Thompson et al. · Neuropharmacology · 2015 · 50 citations · Full text

Functional Selectivity, Medicine, Positive Allosteric Modulator +10

Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: Effects of combined treatment and possible mechanisms of action

Hanna Iderberg, Daniella Rylander Ottosson, Zisis Bimpisidis et al. · Experimental Neurology · 2013 · 46 citations

Functional Selectivity, Medicine, Immunology +8